Japanese phase III trial of prasugrel in patients with ischaemic stroke

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 15 Mar 2013

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Prasugrel (Primary)
Indications Embolism and thrombosis; Stroke
Focus Registrational; Therapeutic Use

Most Recent Events

14 Mar 2013 This trial is ongoing and is expected to complete in the Japanese fiscal year (1 April to 31 March) 2014, according to a Daiichi Sankyo Company media release.
03 Feb 2012 New trial record
31 Jan 2012 The trial is expected to complete between fiscal year (31 March) 2013 and fiscal year 2014, according to a Daiichi Sankyo Company media release.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight